{"id":155767,"date":"2024-04-24T12:45:15","date_gmt":"2024-04-24T12:45:15","guid":{"rendered":"https:\/\/dailytalks.org\/?p=155767"},"modified":"2024-04-24T12:45:15","modified_gmt":"2024-04-24T12:45:15","slug":"ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=155767","title":{"rendered":"Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patients"},"content":{"rendered":"<p>MedPage Today) &#8212; DENVER  &#8212;  Among Black\/African American and Hispanic\/Latino patients with relapsing multiple sclerosis (MS) in the phase IV CHIMES trial, half achieved a combined measure for no evidence of disease activity (NEDA) with ocrelizumab&#8230;<br \/><a href=\"https:\/\/www.medpagetoday.com\/meetingcoverage\/aan\/109739\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MedPage Today) &#8212; DENVER &#8212; Among Black\/African American and Hispanic\/Latino patients with relapsing multiple sclerosis<\/p>\n","protected":false},"author":1,"featured_media":155768,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[41],"tags":[],"class_list":["post-155767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients.jpg",1600,900,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-300x169.jpg",300,169,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-768x432.jpg",640,360,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-1024x576.jpg",640,360,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients.jpg",1600,900,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-1024x576.jpg",1024,576,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2024\/04\/155767-ocrelizumab-trial-fills-research-gap-for-black-hispanic-ms-patients-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=41\" rel=\"category\">Americas<\/a>","tag_info":"Americas","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/155767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=155767"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/155767\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/155768"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=155767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=155767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=155767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}